JP2005516030A5 - - Google Patents

Download PDF

Info

Publication number
JP2005516030A5
JP2005516030A5 JP2003558007A JP2003558007A JP2005516030A5 JP 2005516030 A5 JP2005516030 A5 JP 2005516030A5 JP 2003558007 A JP2003558007 A JP 2003558007A JP 2003558007 A JP2003558007 A JP 2003558007A JP 2005516030 A5 JP2005516030 A5 JP 2005516030A5
Authority
JP
Japan
Prior art keywords
meloxicam
crystalline form
temperature
water
following
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003558007A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005516030A (ja
Filing date
Publication date
Priority claimed from ES200102743A external-priority patent/ES2223209B1/es
Application filed filed Critical
Publication of JP2005516030A publication Critical patent/JP2005516030A/ja
Publication of JP2005516030A5 publication Critical patent/JP2005516030A5/ja
Pending legal-status Critical Current

Links

JP2003558007A 2001-12-11 2002-11-19 新規な結晶性の形態のメロキシカム並びにそれらの製造及び相互転換方法 Pending JP2005516030A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200102743A ES2223209B1 (es) 2001-12-11 2001-12-11 Nuevas formas cristalinas del meloxicam y procedimientos para su preparacion e interconversion.
PCT/ES2002/000539 WO2003057692A1 (es) 2001-12-11 2002-11-19 Nuevas formas cristalinas del meloxicam y procedimientos para su preparacion e interconversion

Publications (2)

Publication Number Publication Date
JP2005516030A JP2005516030A (ja) 2005-06-02
JP2005516030A5 true JP2005516030A5 (https=) 2006-01-05

Family

ID=8499703

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003558007A Pending JP2005516030A (ja) 2001-12-11 2002-11-19 新規な結晶性の形態のメロキシカム並びにそれらの製造及び相互転換方法

Country Status (18)

Country Link
US (1) US6967248B2 (https=)
EP (1) EP1462451B1 (https=)
JP (1) JP2005516030A (https=)
KR (1) KR100919927B1 (https=)
AT (1) ATE318813T1 (https=)
AU (1) AU2002350753B2 (https=)
CA (1) CA2470164A1 (https=)
DE (1) DE60209537T2 (https=)
DK (1) DK1462451T3 (https=)
ES (2) ES2223209B1 (https=)
HU (1) HUP0402536A3 (https=)
MX (1) MXPA04005338A (https=)
NO (1) NO326746B1 (https=)
NZ (1) NZ533521A (https=)
PL (1) PL370435A1 (https=)
PT (1) PT1462451E (https=)
WO (1) WO2003057692A1 (https=)
ZA (1) ZA200404475B (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) * 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1568369A1 (en) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
ITMI20041918A1 (it) * 2004-10-11 2005-01-11 A M S A Anonima Materie Sintetiche Affini Spa Processo di purificazione di meloxicam
HU227359B1 (en) * 2004-12-18 2011-04-28 Egis Gyogyszergyar Nyilvanosan Mikodi Ruszvunytarsasag Process for producing meloxicam and meloxicam potassium salt of high purity
FR2889847B1 (fr) 2005-08-18 2007-10-05 Sanofi Aventis Sa Derives de 5-pyridazinyl-1-azabicyclo[3.2.1]octave, leur preparation en therapeutique.
AU2006298895B9 (en) * 2005-09-30 2013-01-24 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical preparation containing meloxicam
GB2443891B (en) * 2006-11-20 2009-04-08 Norbrook Lab Ltd Process for the purification of meloxicam
WO2009094155A1 (en) * 2008-01-22 2009-07-30 Thar Pharmaceuticals In vivo studies of crystalline forms of meloxicam
MX389960B (es) * 2009-10-12 2025-03-20 Boehringer Ingelheim Vetmedica Gmbh Recipientes para composiciones que comprenden meloxicam.
CA2791805A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
CN103772378B (zh) * 2014-01-26 2016-02-24 悦康药业集团有限公司 一种美洛昔康化合物及其片剂
US20210322316A1 (en) * 2016-11-18 2021-10-21 Pacira Pharmaceuticals, Inc. Zinc meloxicam complex microparticles and anesthetic formulations and processes for making the same
EP3541815A4 (en) * 2016-11-18 2020-07-15 Pacira Pharmaceuticals, Inc. ZINC MELXICAM COMPLEX MICROPARTICLE MULTIVESICULAR LIPOSOME FORMULATIONS AND METHODS OF MAKING THE SAME
CN113710231A (zh) 2019-04-22 2021-11-26 麦兰专业有限合伙公司 美洛昔康共晶组合物
WO2022097024A1 (en) 2020-11-06 2022-05-12 Mylan Laboratories Ltd Pharmaceutical composition comprising meloxicam
CN116421567B (zh) * 2023-04-27 2025-02-07 浙江萃泽医药科技有限公司 一种稳定冻干制剂及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2756113A1 (de) 1977-12-16 1979-06-21 Thomae Gmbh Dr K Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US6355666B1 (en) * 2000-06-23 2002-03-12 Medinox, Inc. Protected forms of pharmacologically active agents and uses therefor

Similar Documents

Publication Publication Date Title
JP2005516030A5 (https=)
CN106928215B (zh) 一种喹嗪酮类化合物的制备方法
JP5247728B2 (ja) ベンズイミダゾール誘導体の製造方法
CN101501000B (zh) 孟鲁司特和其胺盐的纯化方法
JPH0631300B2 (ja) 結晶性アジスロマイシン2水和物及びその製法
CN1227233C (zh) 纯晶形的5-氯-3-(4-甲磺酰基苯基)-6′-甲基-[2,3′]联吡啶及其合成方法
JP2000502101A (ja) ベンゾイミダゾール化合物の合成法
JP2005516030A (ja) 新規な結晶性の形態のメロキシカム並びにそれらの製造及び相互転換方法
US20060069263A1 (en) Process for the reduction of (S)-2-amino-6-propionamido-4,5,6,7-tetrahydrobenzo-thiazole
JP4560293B2 (ja) 医薬上有効な化合物(グラニセトロン)の製造方法
CN1056686A (zh) 制备取代的吲哚酮衍生物的改进方法
EP2477973A1 (en) Process for the preparation of a crystalline form of lenalidomide
AU2001278094A1 (en) Novel crystalline forms of 4-[4-[4-(hydroxydiphenylmethyl)-1-piperindinyl]-1-hydroxybutyl]-alpha, alpha-dimethylbenzene acetic acid and its hydrochloride
WO2002102777A2 (en) NOVEL CRYSTALLINE FORMS OF 4-[4-[4-(HYDROXYDIPHENYLMETHYL)-1-PIPERINDINYL]-1-HYDROXYBUTYL]-α, α-DIMETHYLBENZENE ACETIC ACID AND ITS HYDROCHLORIDE
CN101146810A (zh) 制备1-取代的1H-咪唑并[4,5-c]喹啉-4-胺化合物的方法及其中间体
CN1199968C (zh) 新的地洛他定盐、其合成方法及其药物组合物
CN1639160A (zh) 卡麦角林晶型ⅰ的制备方法
JP2010043053A (ja) 高純度のレバミピドの製造方法
CN1705661A (zh) 制备利培酮的方法
JP2009501764A (ja) 4β−アミノ−4’−デメチル−4−デゾキシポドフィロトキシンの調製方法
TW200844100A (en) Regio-selective Ullmann synthesis of 4-bromo-3-methyl-5-propoxy-thiophene-2-carboxylic acid
JP2020515553A (ja) 1−(4−メタンスルホニル−2−トリフルオロメチル−ベンジル)−2−メチル−1H−ピロロ[2,3−b]ピリジン−3−イル−酢酸を調製するためのプロセス
CN114163388A (zh) 芬苯达唑中的杂质i、杂质ⅱ和杂质ⅲ的制备方法
WO2001070747A1 (en) Process for producing camptothecin
CN105085431B (zh) 4‑(4‑甲氨烯基苯基)‑3‑吗啉酮及其制备方法